The Legal Examiner Affiliate Network The Legal Examiner The Legal Examiner The Legal Examiner search feed instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content
Medication drug needle syringe drug,medical Vaccine vial hypodermic injection treatment disease care in hospital and prevention illness
Inserra | Kelley | Sewell
(800) 642-1242

Beovu (brolucizumab) is used to treat patients with wet age-related macular degeneration (AMD), a chronic eye disorder.  AMD is the leading cause of vision loss for people 50 years and older and it may cause a person to struggle reading fine print and have dark vision blurriness in the center of their vision.  Novartis the drug manufacturer of Beovu released a press statement confirming that Beovu may cause “retinal vasculitis and/or retinal vascular occlusion that may result in severe vision loss.”

Symptoms you may have after receiving a Beovu Injection:

  • Changes in your vision, including floaters 
  • Pain or redness in the eye
  • Bleeding in or around the eye
  • Swelling in the eyelid
  • Hives, rash, redness or itching

If you or a loved one have suffered from severe side effects or blindness from a Beovu injection, please call the mass tort Team at Inserra Kelley Sewell to see whether you might be entitled to compensation. 

Comments for this article are closed, but you may still contact the author privately.